Related Experiment Video
Updated: May 17, 2026
06:03
Operational and Intervention Effects of Targeted Tuina in Lumbar Intervertebral Disc Degeneration Model Rabbits
Published on: July 21, 2023
Tissue renin-angiotensin system in the intervertebral disc
Ryo Morimoto1, Koji Akeda, Ryu Iida
1Departments of Orthopaedic Surgery, Mie University Graduate School of Medicine, Mie, Japan.
Spine
|November 8, 2012
Summary
The study found that the tissue renin-angiotensin system (tRAS) is present in normal rat intervertebral discs (IVDs). This discovery opens new avenues for understanding IVD degeneration and potential therapeutic targets.
Area of Science:
- Biochemistry
- Molecular Biology
- Cell Biology
Background:
- The tissue renin-angiotensin system (tRAS) plays a role in inflammation and fibrosis in various organs.
- The presence and function of tRAS in the intervertebral disc (IVD) have not been previously established.
- Angiotensin II (Ang II) is a key effector molecule within the tRAS pathway.
Purpose of the Study:
- To investigate the expression and functional role of the tRAS within the rat intervertebral disc (IVD).
Main Methods:
- Utilized real-time polymerase chain reaction (PCR) and immunohistochemistry to detect tRAS components in rat and bovine IVD tissues.
- Cultured rat annulus fibrosus cells to assess the in vitro biological functions of tRAS.
- Quantified the impact of Ang II on extracellular matrix metabolism via real-time PCR.
Main Results:
- Confirmed the presence of mRNA for key tRAS components (ACE, Ang II, AT1R, AT2R, Cathepsin D) in rat IVDs.
- Immunohistochemistry revealed expression of tRAS components at the protein level in both rat and bovine IVD cells and tissues.
- Ang II demonstrated a mild stimulatory effect on rat annulus fibrosus cell proliferation and extracellular matrix component expression.
Conclusions:
- This study provides the first evidence for the presence of functional tRAS components at both mRNA and protein levels in the normal rat IVD.
- Further research is warranted to explore the role of tRAS in the pathogenesis of human IVD degeneration.
- Understanding tRAS in IVD degeneration may reveal novel therapeutic strategies.
Related Concept Videos
01:23Degenerative Disc Disease ll: Pathophysiology
The symptoms of degenerative disc disease arise from a combination of mechanical compression, vascular compromise, and biochemical inflammation, which together disrupt nerve function and produce pain.Mechanical CompressionDisc degeneration reduces height and elasticity, predisposing to herniation of the nucleus pulposus, a major cause of radicular pain. Herniations may be protrusion (bulging with intact annulus), extrusion (nucleus extends beyond disc but remains connected), or sequestration...
01:27Degenerative Disc Disease I: Introduction
Degenerative disc disease is a chronic condition in which intervertebral discs gradually lose structure and function. It is not infectious or autoimmune; rather, it results from age-related biochemical and mechanical changes, influenced by genetic, metabolic, and environmental factors.Structure and Function of DiscsThe spine contains 23 intervertebral discs that absorb load, distribute forces, maintain spacing, and allow flexibility. Each disc consists of a nucleus pulposus, a gel-like core...
01:29Herniated Intervertebral Disc l: Introduction
Intervertebral disc herniation refers to the displacement of the nucleus pulposus (the gel-like inner core of the disc) through a tear or weakened area in the annulus fibrosus (the outer fibrous ring). The displaced disc material extends beyond the normal boundaries of the disc space and may compress or irritate nearby spinal nerve roots or, less commonly, the spinal cord.Etiology and Risk FactorsHerniation commonly results from degeneration, in which aging reduces disc hydration and...
01:30Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
01:25Antihypertensive Drugs: Direct Renin Inhibitors
The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
01:29Hypertension II: Pathophysiology
Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...